Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept Frazier Life Sciences launches Callio Therapeutics based on multi-payload antibody-drug conjugate technology… CISION PRNewswireMarch 3, 2025
CBAK Energy to Participate at Upcoming Jefferies 6th Asia Forum in Hong Kong DALIAN, China, March 3, 2025 /PRNewswire/ — CBAK Energy Technology, Inc. (NASDAQ:… CISION PRNewswireMarch 3, 2025
Frost & Sullivan Recognizes Cynerio for Advancing Healthcare Cybersecurity with Its NDR-H Solution to Combat Cyber Threats Cynerio’s NDR-H Solution enables deep packet inspection, comprehensive network traffic analysis with… CISION PRNewswireMarch 3, 2025
Paeonia Industries Announces Acquisition of the Savant Group of companies MIDLAND, Mich., March 3, 2025 /PRNewswire/ — Paeonia Industries, a premier global firm… CISION PRNewswireMarch 3, 2025
Visionary Enters the New Energy Vehicle Field with Eyes on the Global Market TORONTO, March 3, 2025 /PRNewswire/ — Recently, Visionary Holdings Inc. (hereinafter referred… CISION PRNewswireMarch 3, 2025
Addentax Group Corp. Regains Compliance with Nasdaq's Minimum Bid Price Requirement SHENZHEN, China, March 3, 2025 /PRNewswire/ — Addentax Group Corp. ("Addentax" or… CISION PRNewswireMarch 3, 2025
Press ReleaseTechESR Unveils Upgraded Digital Presence Reflecting Its Focus on Innovation and Technology Transformation from ESR Gear to ESR Tech further advances the mission of "Tech… CISION PRNewswireMarch 3, 2025
Press ReleaseZekoAI: Powering Private, Decentralized, and Automated Artificial Intelligence Workflows SAN FRANCISCO, March 3, 2025 /PRNewswire/ — The convergence of artificial intelligence, zero-knowledge,… CISION PRNewswireMarch 3, 2025
